Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

Misuse, Opioid

Interventions

DRUG

Olanzapine

Given by PO

DRUG

Olanzapine

Given by PO

DRUG

Placebo

Given by PO

Trial Locations (1)

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER